Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Toxicol Lett ; 392: 75-83, 2024 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-38160862

RESUMO

Precision-cut lung slices (PCLS) are a suitable model for analyzing the acetylcholinesterase (AChE) activity and subsequent effects after exposure to organophosphorus (OP) compounds. In this study, the AChE activity was determined in intact PCLS for the first time. Since the current standard therapy for OP poisoning (atropine + oxime + benzodiazepine) lacks efficiency, reliable models to study novel therapeutic substances are needed. Models should depict pathophysiological mechanisms and help to evaluate the beneficial effects of new therapeutics. Here PCLS were exposed to three organophosphorus nerve agents (OPNAs): sarin (GB), cyclosarin (GF), and VX. They were then treated with three reactivators: HI-6, obidoxime (OBI), and a non-oxime (NOX-6). The endpoints investigated in this study were the AChE activity and the airway area (AA) change. OPNA exposure led to very low residual AChE activities. Depending on the reactivator properties different AChE reactivation results were measured. GB-inhibited PCLS-AChE was reactivated best, followed by VX and GF. To substantiate these findings and to understand the connection between the molecular and the functional levels in a more profound way the results were correlated to the AA changes. These investigations underline the importance of reactivator use and point to the possibilities for future improvements in the treatment of OPNA-exposed victims.


Assuntos
Reativadores da Colinesterase , Intoxicação por Organofosfatos , Compostos Organotiofosforados , Humanos , Acetilcolinesterase , Reativadores da Colinesterase/farmacologia , Reativadores da Colinesterase/uso terapêutico , Inibidores da Colinesterase , Compostos Organofosforados/toxicidade , Oximas/farmacologia , Oximas/uso terapêutico , Intoxicação por Organofosfatos/tratamento farmacológico , Pulmão
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA